01.05.2008 | Original Articles
Safety of regadenoson, a selective adenosine A2A agonist, in patients with chronic obstructive pulmonary disease: A randomized, double-blind, placebo-controlled trial (RegCOPD trial)
Erschienen in: Journal of Nuclear Cardiology | Ausgabe 3/2008
Einloggen, um Zugang zu erhalten